This may be explained by preserved tumor sensitivity to beta radiation and suggests 161Tb as a potential alternative to conventional 177Lu based PSMA RLT, exploiting the advantages of the high proportion of low-energy conversion and Auger electrons. The gene discussed is FOLH1; the disease is neoplasm.